Telesis Bio Management
Management criteria checks 0/4
Telesis Bio's CEO is Eric Esser, appointed in Jun 2022, has a tenure of 1.92 years. directly owns 0.016% of the company’s shares, worth $1.74K. The average tenure of the management team and the board of directors is 1.9 years and 3 years respectively.
Key information
Eric Esser
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.9yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.9yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
The Market Lifts Telesis Bio, Inc. (NASDAQ:TBIO) Shares 38% But It Can Do More
Apr 17
Codex DNA GAAP EPS of -$0.50, revenue of $5.7M; raises FY22 guidance
Aug 09Codex DNA, Inc. (NASDAQ:DNAY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This Space
Jan 06Codex: Synthetic DNA/mRNA Instrument Developer Holds Impressive Upside In 2021
Sep 24CEO
Eric Esser (54 yo)
1.9yrs
Tenure
Mr. Eric Esser serves as President of Telesis Bio, Inc. since May 1, 2023 and serves as its CEO & Director since April 18, 2024. He serves as Chief Operating Officer at Telesis Bio, Inc. (formerly known as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | no data | US$2.31m | 20.72% $ 2.3m | |
| Chief Technology Officer | 5.8yrs | US$1.33m | 0.31% $ 33.3k | |
| Chief Legal Officer | 2.8yrs | US$1.41m | 0.056% $ 6.1k | |
| President | 1.9yrs | no data | 0.016% $ 1.7k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | 1.4yrs | no data | no data | |
| Senior Vice President of Corporate Development | no data | no data | no data | |
| Director of Investor Relations | no data | no data | no data |
1.9yrs
Average Tenure
55yo
Average Age
Experienced Management: TBIO's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | 5.8yrs | US$2.31m | 20.72% $ 2.3m | |
| President | less than a year | no data | 0.016% $ 1.7k | |
| Independent Director | 3yrs | US$180.80k | 0.069% $ 7.4k | |
| Independent Chair of the Board | 3.4yrs | US$244.86k | 0.43% $ 47.2k | |
| Independent Director | 2.9yrs | US$165.36k | 0.069% $ 7.4k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 1.8yrs | US$271.51k | 0.084% $ 9.2k | |
| Member of Strategic Advisory Board | no data | no data | no data | |
| Member of Strategic Advisory Board | no data | no data | no data | |
| Independent Director | 3yrs | no data | 0% $ 0 |
3.0yrs
Average Tenure
60.5yo
Average Age
Experienced Board: TBIO's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.